Lupus for Doctors

FDA Approves Lupkynis (voclosporin) for Adult Patients with Active Lupus Nephritis

VICTORIA, British Columbia& ROCKVILLE, Md.-- January 22, 2021 -- Aurinia Pharmaceuticals Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved Lupkynis (voclosporin) in combination with a background... (Source: Drugs.com - New Drug Approvals)

MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.

Read More

More Than 200,000 Americans Have Lupus

A new study reveals how widespread the disease is in the United States. (Source: WebMD Health)

MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.

Read More

More Than 200,000 Americans Have Lupus

A new study reveals how widespread the disease is in the United States.

Read More

Study Reveals New Insights into the Link Between Sunlight Exposure and Kidney Damage in Lupus

A new collaborative study from researchers at the Geisel School of Medicine at Dartmouth and the University of Washington and published in the Proceedings of the National Academy of Sciences (PNAS), reveals unexpected insights into how skin exposure to ultraviolet light can worsen clinical symptoms in autoimmune diseases such as lupus. (Source: News at Dartmouth Medical School)

MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.

Read More

Study Estimates Prevalence of Lupus in the U.S.

THURSDAY, Jan. 21, 2021 -- The estimated prevalence of systemic lupus erythematosus (SLE) in the United States is 72.8/100,000, according to a study published online Jan. 21 in Arthritis& Rheumatology. Peter M. Izmirly, M.D., from the New York... (Source: Drugs.com - Pharma News)

Read More